Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1–3 clinical trials: A Children’s Cancer and Leukaemia Group (CCLG) study
Titel:
Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1–3 clinical trials: A Children’s Cancer and Leukaemia Group (CCLG) study
Auteur:
Messahel, Boo Williams, Richard Ridolfi, Antonia A’Hern, Roger Warren, William Tinworth, Lorna Hobson, Rachel Al-Saadi, Reem Whyman, Gavin Brundler, Marie-Anne Kelsey, Anna Sebire, Neil Jones, Chris Vujanic, Gordan Pritchard-Jones, Kathy